NO931338L - RELATIONSHIPS AND PROCEDURES FOR INHIBITING HIV AND RELATED VIRUSES - Google Patents

RELATIONSHIPS AND PROCEDURES FOR INHIBITING HIV AND RELATED VIRUSES

Info

Publication number
NO931338L
NO931338L NO93931338A NO931338A NO931338L NO 931338 L NO931338 L NO 931338L NO 93931338 A NO93931338 A NO 93931338A NO 931338 A NO931338 A NO 931338A NO 931338 L NO931338 L NO 931338L
Authority
NO
Norway
Prior art keywords
relationships
procedures
inhibiting hiv
related viruses
compound
Prior art date
Application number
NO93931338A
Other languages
Norwegian (no)
Other versions
NO931338D0 (en
Inventor
Peter Thomas Lind
Jr John Michael Morin
Rolf Noreen
Robert John Tarnansky
Original Assignee
Medivir Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from NO92922949A external-priority patent/NO922949L/en
Publication of NO931338L publication Critical patent/NO931338L/en
Application filed by Medivir Ab filed Critical Medivir Ab
Priority to NO931338A priority Critical patent/NO931338D0/en
Publication of NO931338D0 publication Critical patent/NO931338D0/en

Links

Abstract

Forbindelse med formel (IA) farmasøytisk formulering som omfatter forbindelsen og anvendelse av forbindelsen for fremstilling av et medikament nyttig for inhibering av replikasjon av HIV, behandling og inhlbisjon av HIV i et menneske og behandling og inhibisjon av ervervet immunsvikt syndrom l et menneske, er beskrevet.Compound of formula (IA) pharmaceutical formulation comprising the compound and use of the compound for the preparation of a drug useful for inhibiting HIV replication, treatment and inhibition of HIV in a human, and treatment and inhibition of acquired immunodeficiency syndrome in a human are described. .

NO931338A 1991-08-02 1993-04-07 RELATIONSHIPS AND PROCEDURES FOR INHIBITING HIV AND RELATED VIRUSES NO931338D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NO931338A NO931338D0 (en) 1991-08-02 1993-04-07 RELATIONSHIPS AND PROCEDURES FOR INHIBITING HIV AND RELATED VIRUSES

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US73992791A 1991-08-02 1991-08-02
NO92922949A NO922949L (en) 1991-08-02 1992-07-24 RELATIONSHIPS AND PROCEDURES FOR INHIBITING HIV AND RELATED VIRUSES
NO931338A NO931338D0 (en) 1991-08-02 1993-04-07 RELATIONSHIPS AND PROCEDURES FOR INHIBITING HIV AND RELATED VIRUSES

Publications (2)

Publication Number Publication Date
NO931338L true NO931338L (en) 1993-02-03
NO931338D0 NO931338D0 (en) 1993-04-07

Family

ID=27353204

Family Applications (1)

Application Number Title Priority Date Filing Date
NO931338A NO931338D0 (en) 1991-08-02 1993-04-07 RELATIONSHIPS AND PROCEDURES FOR INHIBITING HIV AND RELATED VIRUSES

Country Status (1)

Country Link
NO (1) NO931338D0 (en)

Also Published As

Publication number Publication date
NO931338D0 (en) 1993-04-07

Similar Documents

Publication Publication Date Title
HUP0500558A2 (en) Low dose entecavir formulation and process for its preparation
HUP0003173A2 (en) Use of glp-1 or analogs for preparing pharmaceutical compositions useful in treatment of myocardial infarction
DK602988D0 (en) NUCLEOSIDE DERIVATIVES WITH ANTIVIRAL EFFECT AND PHARMACEUTICAL PREPARATIONS CONTAINING SUCH COMPOUNDS
AR024227A1 (en) INHIBITING PYRIMIDINES OF HIV REPLICATION, A PROCESS FOR PREPARATION, THE USE OF THE SAME FOR THE MANUFACTURE OF A MEDICINAL PRODUCT, PHARMACEUTICAL COMPOSITIONS, AND A PROCESS TO PREPARE THEM
RU2329050C2 (en) Combination of cytochrome-p450-dependent protease inhibitors
HUP0401998A2 (en) The use of pde 9 inhibitors for production of those medicine being useful in the treatment of insulin resistance syndrome and type 2 diabetes
MX9204454A (en) THIOUREA DERIVATIVES TO INHIBIT THE REPLICATION OF THE HUMAN IMMUNODEFICIENCY VIRUS AND THE PHARMACEUTICAL FORMULATE CONTAINING THEM.
AR019853A1 (en) DERIVED FROM THE 3-ARIL-2-HYDROXIPROPIONIC ACID, PROCESS AND INTERMEDIARY FOR THEIR PREPARATION, PHARMACEUTICAL FORMULATIONS, USE OF SUCH COMPOUND IN THE PREPARATION OF A MEDICINAL PRODUCT, METHOD FOR THE PROPHYLAXIS AND / OR TREATMENT OF CLINIC ASSOCIATED RESISTANCES AND FORMULATION
DK0506539T3 (en) heterocyclic alkylamides, processes for their preparation and pharmaceutical agents containing them
DE69019533D1 (en) TREATMENT OF HIV INFECTIONS AND USEFUL LINKS THEREFOR.
ES2062610T3 (en) DIARILIC ANTI-ATEROSCLEROTIC COMPOUND.
ATE182271T1 (en) MEDICINAL PRODUCTS FOR THE TREATMENT OF CANCER, AIDS AND VIRUS DISEASES
NO962752L (en) Use of 2,3-diaryl-1-benzopyran derivatives in the manufacture of a medicament for the treatment and prevention of bone loss and osteoporosis
NO912414L (en) RELATIONSHIP WITH MAGIC ACID INHIBITING EFFECT AND PROCEDURE FOR ITS MANUFACTURING.
TR200102512T2 (en) The use of saredutan and its pharmaceutically acceptable salts for the preparation of medicinal products useful in the treatment or prevention of all mental disorders, adaptation disorders and various anxiety-depression disorders.
DK0859613T3 (en) Use of flupirtine for the prevention and treatment of diseases associated with damage to the hemopoietic cell system
ATE192926T1 (en) COMPOSITION CONTAINING FLAVOPEREIRINE AND ITS USE IN THE TREATMENT AGAINST HIV VIRUSES
RU98111152A (en) The use of the active substance flupirtine or its pharmacologically acceptable salts as a drug for the prevention and treatment of diseases associated with damage to the cell system
EA200600679A1 (en) PHARMACEUTICAL COMPOSITION OF CONTROLLED GRIPPING AND METHOD OF ITS PREPARATION
NO931338L (en) RELATIONSHIPS AND PROCEDURES FOR INHIBITING HIV AND RELATED VIRUSES
EP0576506B1 (en) Use of benzimidazole anthelmintic in the treatment of microsporidial infections
KR950702838A (en) Method for inhibiting HIV replication using IL-4 using interleukin-4 (IL-4)
NO931337L (en) RELATIONSHIPS AND PROCEDURES FOR INHIBITING HIV AND RELATED VIRUSES
DK1143976T3 (en) Beta-D-2 ', 3'-didehydro-2', 3'-dideoxy-5-fluorocytidine for use in the treatment of HIV infections
HUP0301415A2 (en) Method for formulating healthcare products with enhanced stability